Accuracy and Feasibility of an Android-Based Digital Assessment Tool for Post Stroke Visual Disorders-The StrokeVision App

Terence J Quinn, Iain Livingstone, Alexander Weir, Robert Shaw, Andrew Breckenridge, Christine McAlpine, Claire M Tarbert, Terence J Quinn, Iain Livingstone, Alexander Weir, Robert Shaw, Andrew Breckenridge, Christine McAlpine, Claire M Tarbert

Abstract

Background: Visual impairment affects up to 70% of stroke survivors. We designed an app (StrokeVision) to facilitate screening for common post stroke visual issues (acuity, visual fields, and visual inattention). We sought to describe the test time, feasibility, acceptability, and accuracy of our app-based digital visual assessments against (a) current methods used for bedside screening and (b) gold standard measures.

Methods: Patients were prospectively recruited from acute stroke settings. Index tests were app-based assessments of fields and inattention performed by a trained researcher. We compared against usual clinical screening practice of visual fields to confrontation, including inattention assessment (simultaneous stimuli). We also compared app to gold standard assessments of formal kinetic perimetry (Goldman or Octopus Visual Field Assessment); and pencil and paper-based tests of inattention (Albert's, Star Cancelation, and Line Bisection). Results of inattention and field tests were adjudicated by a specialist Neuro-ophthalmologist. All assessors were masked to each other's results. Participants and assessors graded acceptability using a bespoke scale that ranged from 0 (completely unacceptable) to 10 (perfect acceptability).

Results: Of 48 stroke survivors recruited, the complete battery of index and reference tests for fields was successfully completed in 45. Similar acceptability scores were observed for app-based [assessor median score 10 (IQR: 9-10); patient 9 (IQR: 8-10)] and traditional bedside testing [assessor 10 (IQR: 9-10); patient 10 (IQR: 9-10)]. Median test time was longer for app-based testing [combined time to completion of all digital tests 420 s (IQR: 390-588)] when compared with conventional bedside testing [70 s, (IQR: 40-70)], but shorter than gold standard testing [1,260 s, (IQR: 1005-1,620)]. Compared with gold standard assessments, usual screening practice demonstrated 79% sensitivity and 82% specificity for detection of a stroke-related field defect. This compares with 79% sensitivity and 88% specificity for StrokeVision digital assessment.

Conclusion: StrokeVision shows promise as a screening tool for visual complications in the acute phase of stroke. The app is at least as good as usual screening and offers other functionality that may make it attractive for use in acute stroke.

Clinical trial registration: https://ClinicalTrials.gov/ct2/show/NCT02539381.

Keywords: apps; assessment; hemianopia; information technology; sensitivity; specificity; stroke; visual neglect.

Figures

Figure 1
Figure 1
Tumbling E Near Acuity Test, adapted from the android-based distance optotype test, “peek acuity lite” (14.5). The patient is asked to swipe in the direction of the limbs of the E and a staircasing algorithm detects the threshold acuity level.
Figure 2
Figure 2
(A) The StrokeApp Visual Field test. The fixation target is the red nose of the smiling face graphic. The fixation target moves to the extreme corners of the device screen and the black circular target emerges from the periphery toward fixation. The peripheral target (black circle) subtends a similar angle to the Goldmann III target setting. The patient is encouraged to tap anywhere on the screen at the moment they detect the emerging peripheral target. The tester observes patient fixation, and if a fixation loss is detected, the screen is swiped to delete the previous input and re-test that point or quadrant. (B) The diagonal hashed lines indicate field defect once reaction time has been accounted for. The red line indicates limit of the visual field before reaction time has been accounted for. (C) StrokeSim. The detected perimetry plot is transposed as a digital filter to the feed from the device back-facing camera. The field within the defect is averaged to a single color.
Figure 3
Figure 3
(A) The Line Crossing test screen. Line thickness is calibrated against the acuity score to allow testing in low-vision patients. The patient is asked to press the perceived center of each line. (B) The Face Cancelation Test. A second test of inattention, whereby the patient is asked to press the small faces. As previous, line thickness is calibrated to acuity score.

References

    1. MacIntosh C. Stroke re-visited: visual problems following stroke and their effect on rehabilitation. Br Orthopt J (2003) 60:1–14.
    1. Rowe FJ, Wright D, Brand D, Jackson C, Harrison S, Maan T, et al. A Prospective Profile of Visual Field Loss Following Stroke: Prevalence, Type, Rehabilitation, and Outcome. BioMed Research International; (2013). Available from: (Accessed: December, 2017).
    1. Stone SP, Halligan PW, Greenwood RJ. The incidence of neglect phenomena and related disorders in patients with an acute right or left hemisphere stroke. Age Ageing (1993) 22(1):46–52.10.1093/ageing/22.1.46
    1. Rowe F. The profile of strabismus in stroke survivors. Eye (2010) 24(4):682–5.10.1038/eye.2009.138
    1. Kalra L, Perez I, Gupta S, Wittink M. The influence of visual neglect on stroke rehabilitation. Stroke (1997) 28(7):1386–91.10.1161/01.STR.28.7.1386
    1. Han L, Law-Gibson D, Reding M. Key neurological impairments influence function-related group outcomes after stroke. Stroke (2002) 33(7):1920–4.10.1161/
    1. Jones SA, Shinton RA. Improving outcome in stroke patients with visual problems. Age Ageing (2006) 35(6):560–5.10.1093/ageing/afl074
    1. University of Glasgow MLVS. Best Practice Statement: Screening, Assessment and Management of Vision Problems in the First 30 Days after an Acute Stroke. (2013). Available from: (Accessed: December, 2017).
    1. Rowe FJ, Walker M, Rockliffe J, Pollock A, Noonan C, Howard C, et al. Care provision for poststroke visual impairment. J Stroke Cerebrovasc Dis (2015) 24(6):1131–44.10.1016/j.jstrokecerebrovasdis.2014.12.035
    1. Aslam TM, Murray IJ, Lai MYT, Linton E, Tahir HJ, Parry NRA. An assessment of a modern touch-screen tablet computer with reference to core physical characteristics necessary for clinical vision testing. J R Soc Interface (2013) 10(84):20130239.10.1098/rsif.2013.0239
    1. Optimisation and Assessment of Three Modern Touch Screen Tablet Computers for Clinical Vision Testing. (2017). Available from: (Accessed: December, 2017).
    1. Livingstone IA, Tarbert CM, Giardini ME, Bastawrous A, Middleton D, Hamilton R. Photometric compliance of tablet screens and retro-illuminated acuity charts as visual acuity measurement devices. PLoS One (2016) 11(3):e0150676.10.1371/journal.pone.0150676
    1. Tarbert CM, Livingstone IAT, Weir AJ. Assessment of visual impairment in stroke survivors. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society Chicago (2014). p. 2185–8.
    1. Bastawrous A, Rono HK, Livingstone IAT, Weiss HA, Jordan S, Kuper H, et al. Development and validation of a smartphone-based visual acuity test (peek acuity) for clinical practice and community-based fieldwork. JAMA Ophthalmol (2015) 133(8):930–7.10.1001/jamaophthalmol.2015.1468
    1. Azouvi P, Samuel C, Louis-Dreyfus A, Bernati T, Bartolomeo P, Beis J-M, et al. Sensitivity of clinical and behavioural tests of spatial neglect after right hemisphere stroke. J Neurol Neurosurg Psychiatry (2002) 73(2):160–6.10.1136/jnnp.73.2.160
    1. Pandit RJ, Gales K, Griffiths PG. Effectiveness of testing visual fields by confrontation. Lancet (2001) 358(9290):1339–40.10.1016/S0140-6736(01)06448-0
    1. Schuetz GM, Schlattmann P, Dewey M. Use of 3×2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies. BMJ (2012) 345:e6717.10.1136/bmj.e6717
    1. Lees RA, Hendry K, Broomfield N, Stott DJ, Larner AJJ, Quinn TJ. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry (2017) 32:1072–8.10.1002/gps.4568
    1. Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database Syst Rev (2013) (3):CD010460.10.1002/14651858.CD010460

Source: PubMed

3
Tilaa